Viewing Study NCT02124902


Ignite Creation Date: 2025-12-25 @ 3:52 AM
Ignite Modification Date: 2026-04-16 @ 6:22 PM
Study NCT ID: NCT02124902
Status: TERMINATED
Last Update Posted: 2022-11-07
First Post: 2014-04-24
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Neoadjuvant Treatment of Triple Negative Breast Cancer Patients With Docetaxel and Carboplatin to Assess Anti-tumor Activity
Sponsor: Washington University School of Medicine
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2014-07-07
Start Date Type: ACTUAL
Primary Completion Date: 2021-11-10
Primary Completion Date Type: ACTUAL
Completion Date: 2021-12-31
Completion Date Type: ACTUAL
First Submit Date: 2014-04-24
First Submit QC Date: None
Study First Post Date: 2014-04-28
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2022-10-12
Results First Submit QC Date: None
Results First Post Date: 2022-11-07
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-10-12
Last Update Post Date: 2022-11-07
Last Update Post Date Type: ACTUAL